MERCER GLOBAL ADVISORS INC /ADV
Position in CATX — Perspective Therapeutics, Inc.
CIK 853758
DENVER, CO
Position in CATX
as of Jun 30, 2026
· filed Aug 19, 2026
Position Value
$75,422
-$17,439 QoQ
Shares Held
22,118
-0.7% QoQ
Ownership
0.019%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#79
of 130 holders
Holding Since
Mar 2024
8 quarters on record
Voting authority
Sole 1%
Shared 0%
None 99%
Common Shares in CATX Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026MERCER GLOBAL ADVISORS INC /ADV holds $220,215,684 across 64 Medical Devices names. CATX ranks #53 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
609,854 | $55,338,151 | |
| 2 | SYK |
Stryker Corp
|
142,133 | $44,749,153 | |
| 3 | MDT |
Medtronic plc
|
504,928 | $39,500,517 | |
| 4 | EW |
Edwards Lifesciences Corp
|
279,851 | $25,315,321 | |
| 5 | BSX |
Boston Scientific Corp
|
206,605 | $8,817,901 | |
| 6 | DXCM |
Dexcom Inc
|
68,879 | $4,639,000 | |
| 7 | PODD |
Insulet Corp
|
27,766 | $4,227,373 | |
| 8 | STE |
STERIS plc
|
19,913 | $4,193,080 |
All Filings in CATX
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $75,422 | 22,118 | Shares | Sole | 2026-08-19 | |
| 2026-03-31 | $92,861 | 22,269 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $76,186 | 27,704 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $100,413 | 29,275 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $55,408 | 16,107 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $34,271 | 16,090 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $51,320 | 16,088 | Shares | Sole | 2025-02-14 | |
| 2024-03-31 | $4 | 4 | Shares | Sole | 2024-05-15 | |
| No filing history on record for this holder in this stock. | ||||||